Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021350
Filing Date
2025-08-08
Accepted
2025-08-08 16:49:31
Documents
1
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 form4-08082025_080828.html 4  
1 form4-08082025_080828.xml 4 8141
  Complete submission text file 0001415889-25-021350.txt   9617
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Peetz Christopher (Reporting) CIK: 0001614740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 251199170

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)